Piramal Pharma Limited Announces Results for Q4 and Full-year FY26
Apr 29, 2026
Mumbai (Maharashtra) [India], April 29: Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Fourth Quarter (Q4) and Full-year ended 31st March 2026.
Read More...